captopril has been researched along with monocrotaline in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Dunne, M; Molteni, A; Solliday, NH; Ts'ao, CH; Ward, WF | 1 |
| Daemen, MJ; Smits, JF; van Suylen, RJ | 1 |
| Baybutt, RC; Halder, A; Herndon, BL; Kamal, R; Mein, J; Molteni, A; Reppert, S; Umbehr, J; Van Dillen, C; Xue, Y | 1 |
| Hara, Y; Harada, T; Hori, Y; Kikuzuki, R; Okada, M; Yamawaki, H | 1 |
| Cho, YK; Choi, WY; Eom, GH; Kee, HJ; Kim, HS; Kook, H; Ma, JS; Nam, KI | 1 |
| de Figueiredo, SG; Gava, PL; Guimarães, MC; Mauad, H; Pereira, FE; Waichert, ÉJ; Wittmer, VL | 1 |
8 other study(ies) available for captopril and monocrotaline
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Monocrotaline-induced pulmonary fibrosis in rats: amelioration by captopril and penicillamine.
Topics: Animals; Body Weight; Captopril; Hydroxyproline; Lung; Male; Monocrotaline; Organ Size; Penicillamine; Peptidyl-Dipeptidase A; Plants, Toxic; Proline; Pulmonary Fibrosis; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Senecio | 1985 |
Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension.
Topics: Adaptation, Physiological; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Blood Pressure; Captopril; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Hypoxia; Male; Monocrotaline; Pulmonary Artery; Rats; Rats, Wistar | 1998 |
Effects on cytokines and histology by treatment with the ACE inhibitor captopril and the antioxidant retinoic acid in the monocrotaline model of experimentally induced lung fibrosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Cytokines; Disease Models, Animal; Male; Monocrotaline; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Tretinoin | 2007 |
Captopril attenuates matrix metalloproteinase-2 and -9 in monocrotaline-induced right ventricular hypertrophy in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Captopril; Disease Models, Animal; Echocardiography; Fibrosis; Gene Expression Regulation; Hypertrophy, Right Ventricular; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Monocrotaline; Myocytes, Cardiac; Rats; Rats, Wistar; Ventricular Dysfunction, Right | 2008 |
Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Histone Deacetylase Inhibitors; Hypertrophy, Right Ventricular; Ligation; Male; Monocrotaline; Rats; Rats, Sprague-Dawley; Valproic Acid | 2010 |
Effects of captopril on cardiovascular reflexes and respiratory mechanisms in rats submitted to monocrotaline-induced pulmonary arterial hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Baroreflex; Captopril; Disease Models, Animal; Hypertension, Pulmonary; Male; Monocrotaline; Rats; Rats, Wistar; Vascular Remodeling | 2015 |